entertainment -WSS

entertainment

author：hotspot 2025-10-02 18:46:43 - browse：84463

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

This week: A chat with Argenx CEO Tim Van Hauwermeiren, and updates on biotech PIPEs, Madrigal Pharmaceuticals, and Annovis Bio.

The Belgian drugmaker Argenx is preparing for a commercial launch this summer that will expand the use of its IgG-lowering antibody Vyvgart to patients with chronic inflammatory demyelinating polyneuropathy, or CIDP, an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Micronoma's microbiome cancer diagnostic approach under fire

Wikipedia

WSS

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Readout Newsletter: BridgeBio, Akero, and human embryo models

Microsoft's Peter Lee: Generative AI could help doctors be more human

What the airline industry can learn from medicine

The untold story of TV’s first prescription drug ad

What the US credit downgrade means for the economy, your finances

Wikipedia

entertainment

Wikipedia

Walensky prepares to leave CDC — and Congress — behind

Immune cells and nerve overgrowth may explain recurring UTI pain

Novavax promises a turnaround & Lilly roils the obesity market

Vertex non

Sports medicine is finally prioritizing gender equality

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Activists slam private health insurers over coverage restrictions

EQRx, failed developer of low

Medical records are filled with copy

Vertex non

hotspot

State of the Union pitch: Bigger Medicare drug price negotiations

NIH launches clinical trials and new research office for long Covid

New safety details link Apellis eye drug to rare cases of blindness

National panel will explore requiring free Covid tests

The public health thinking behind the CDC’s new Covid guidance

5 important ways Henrietta Lacks changed medical science

focus

explore

focus

leisure time